Author

Shaji Sebastian

OpenAlex ID: A5135141011

Clinical utility of pre-treatment four-digit-resolution HLA genotyping to guide anti-tumor necrosis factor choice and concomitant immunomodulator use

2025 · Phoebe Hodges, Christopher Roberts, et al. · Journal of Crohn s and Colitis · 3

982 Randomised Controlled Trial of Withdrawal of Thiopurines When Switching From Intravenous to Subcutaneous Infliximab: Results of the Minimise Study

2026 · Peter M. Irving, Andrea Centritto, et al. · Gastroenterology · 1

98 Safety of Guselkumab in Patients Aged ≥60 Years With Immune-mediated Inflammatory Diseases: a Pooled Analysis of Registrational Trials in Uc, Cd, Psa and Pso

2026 · Adam S. Faye, Shaji Sebastian, et al. · Gastroenterology

Mo1510 MOLECULAR AND CELLULAR SIGNATURES ACCOMPANYING EARLY DISEASE CLEARANCE IN ULCERATIVE COLITIS PATIENTS TREATED WITH VEDOLIZUMAB IN THE VERDICT TRIAL

2026 · Saurabh Mehandru, Nick Powell, et al. · Gastrointestinal Endoscopy

Su1623 GLOBAL PERSPECTIVES ON SUSTAINABLE INFLAMMATORY BOWEL DISEASE CARE: RESULTS FROM AN INTERNATIONAL SURVEY

2026 · Olga Maria Nardone, Silvio Danese, et al. · Gastroenterology

Tu1555 SAFETY OF BIOLOGIC INITIATION IN PREGNANCY AND THE ROLE OF JOINT INFLAMMATORY BOWEL DISEASE-ANTENATAL CLINICS IN IMPROVING PREGNANCY OUTCOMES: A LARGE UK MULTICENTRE COHORT

2026 · Krishna Shah, Kathryn Dalrymple, et al. · Gastrointestinal Endoscopy

982 Randomised Controlled Trial of Withdrawal of Thiopurines When Switching From Intravenous to Subcutaneous Infliximab: Results of the Minimise Study

2026 · Peter M. Irving, Andrea Centritto, et al. · Gastrointestinal Endoscopy

Sa1609 BURDEN OF CERVICAL DYSPLASIA AND CANCER IN INFLAMMATORY BOWEL DISEASE: A COMPREHENSIVE META-ANALYSIS ACROSS DISEASE SUBTYPES AND IMMUNOSUPPRESSIVE THERAPIES

2026 · Mythili Menon Pathiyil, Abhirup Chatterjee, et al. · Gastroenterology

Mo1510 MOLECULAR AND CELLULAR SIGNATURES ACCOMPANYING EARLY DISEASE CLEARANCE IN ULCERATIVE COLITIS PATIENTS TREATED WITH VEDOLIZUMAB IN THE VERDICT TRIAL

2026 · Saurabh Mehandru, Nick Powell, et al. · Gastroenterology

98 Safety of Guselkumab in Patients Aged ≥60 Years With Immune-mediated Inflammatory Diseases: a Pooled Analysis of Registrational Trials in Uc, Cd, Psa and Pso

2026 · Adam S. Faye, Shaji Sebastian, et al. · Gastrointestinal Endoscopy

Tu1555 SAFETY OF BIOLOGIC INITIATION IN PREGNANCY AND THE ROLE OF JOINT INFLAMMATORY BOWEL DISEASE-ANTENATAL CLINICS IN IMPROVING PREGNANCY OUTCOMES: A LARGE UK MULTICENTRE COHORT

2026 · Krishna Shah, Kathryn Dalrymple, et al. · Gastroenterology

Sa1609 BURDEN OF CERVICAL DYSPLASIA AND CANCER IN INFLAMMATORY BOWEL DISEASE: A COMPREHENSIVE META-ANALYSIS ACROSS DISEASE SUBTYPES AND IMMUNOSUPPRESSIVE THERAPIES

2026 · Mythili Menon Pathiyil, Abhirup Chatterjee, et al. · Gastrointestinal Endoscopy

Su1623 GLOBAL PERSPECTIVES ON SUSTAINABLE INFLAMMATORY BOWEL DISEASE CARE: RESULTS FROM AN INTERNATIONAL SURVEY

2026 · Olga Maria Nardone, Silvio Danese, et al. · Gastrointestinal Endoscopy

Acnmd26-231: Global Perspectives on Sustainable Inflammatory Bowel Disease Care: Results From an International Survey

2026 · Olga Nardone, Silvio Danese, et al. · Digestive and Liver Disease

Works count: 14

Citation count: 4

H-index: 1

I10-index: